Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Johnson and Johnson
Cipla
Fuji
Queensland Health
Healthtrust
Covington

Generated: April 26, 2018

DrugPatentWatch Database Preview

PEGANONE Drug Profile

« Back to Dashboard

When do Peganone patents expire, and what generic alternatives are available?

Peganone is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in PEGANONE is ethotoin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ethotoin profile page.
Drug patent expirations by year for PEGANONE
Synonyms for PEGANONE
(.+/-.)-Ethotoin
(+-)-3-Ethyl-5-phenylhydantoin
1-ethyl-2-hydroxy-4-phenyl-4,5-dihydro-1H-imidazol-5-one
1-Ethyl-2,5-dioxo-4-phenylimidazolidine
2,4-Imidazolidinedione, 3-ethyl-5-phenyl-
2,4-Imidazolidinedione, 3-ethyl-5-phenyl-, (+-)-
3-Ethyl-5-phenyl-2,4-imidazolidinedione
3-Ethyl-5-phenyl-2,4-imidazolidinedione #
3-ethyl-5-phenyl-imidazolidine-2,4-dione
3-Ethyl-5-phenylhydantoin
3-Ethyl-5-phenylimidazolidin-2,4-dione
3-ethyl-5-phenylimidazolidine-2,4-dione
5-24-08-00005 (Beilstein Handbook Reference)
86-35-1
AB00513897
AB00513897_07
Abbott brand of ethotoin
AC1L1FLQ
Accenon
Accenon (TN)
AKOS008947805
API0009008
BPBio1_000937
BRN 0188272
BSPBio_000851
C07839
CAS-86-35-1
CCG-213433
CHEBI:4888
CHEMBL1095
D00708
D05EPM
DB00754
DSSTox_CID_3020
DSSTox_GSID_23020
DSSTox_RID_76833
DTXSID6023020
EINECS 201-665-1
ethotoin
ETHOTOIN (200 MG)
Ethotoin (JAN/USP/INN)
Ethotoin [INN:BAN:JAN]
Ethotoin [USP:INN:BAN:JAN]
Ethotoine
Ethotoine [INN-French]
Ethotoinum
Ethotoinum [INN-Latin]
Etotoina
Etotoina [INN-Spanish]
GTPL7183
HE044071
HE166415
HE398382
HMS1570K13
HMS2097K13
HMS2232M06
HMS3371O03
HSDB 3580
Hydantoin, 3-ethyl-5-phenyl-
LS-76194
MCULE-6544505383
MFCD00072127
MLS002153961
MolPort-003-666-682
NCGC00016340-01
NCGC00179401-01
NCGC00179401-03
NSC-760074
NSC760074
Oprea1_374844
Peganone (TN)
Pegoanone
Pharmakon1600-01505428
Prestwick0_000696
Prestwick1_000696
Prestwick2_000696
Prestwick3_000696
SCHEMBL34301
SMR001233300
SPBio_002772
SR-01000841832
SR-01000841832-2
SZQIFWWUIBRPBZ-UHFFFAOYSA-N
Tox21_110383
Z53845223

US Patents and Regulatory Information for PEGANONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare PEGANONE ethotoin TABLET;ORAL 010841-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare PEGANONE ethotoin TABLET;ORAL 010841-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Accenture
Chinese Patent Office
Citi
Chubb
US Department of Justice
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.